晚期胆道癌的二线化疗的疗效:系统性审查和网络元分析
Inhwan Hwang1, Sangah Han2, Ji Hun Jeong3
1Department of Oncology, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.
Journal of hepato-biliary-pancreatic sciences
|January 20, 2025
概括
对于胆道癌症 (BTC) 患者来说,纳米脂质体内诺基素加上甲和LV (nal-IRI_5FU_LV) 显示为二线化疗最有前途,改善了整体存活率 (OS) 和无进展存活率 (PFS). 这些证据指导了最佳治疗选择.
科学领域:
- 在瘤学瘤学.
- 医学化学 医学化学
- 临床试验 临床试验
背景情况:
- 胆道癌 (BTC) 治疗需要有效的二线化疗选择.
- 基于的第一线治疗失败需要优化后续治疗策略.
研究的目的:
- 为选择BTC的二线化疗提供基于证据的指导.
- 为了比较各种化疗剂对高级BTC的疗效.
主要方法:
- 随机对照试验 (RCT) 和队列研究的网络元分析 (NMA).
- 在PubMed,Cochrane和EMBASE的文献搜索到2024年7月.
- 包括二线化疗后白金疗法的研究,测量整体生存 (OS) 和无进展生存 (PFS) 危险比率 (HR).
主要成果:
- 分析了8项涉及1621名患者的研究.
- 对于OS,5FU加Plat (HR 0.52),nal-IRI_5FU_LV (HR 0.54),和FOLFOX (HR 0.69) 与对照组相比显示出显著的好处.
- 纳尔-IRI_5FU_LV表现出比5FU.显著的PFS优势 (HR 0.61) 在5FU.
结论:
- 纳米脂质体内氨基酸与甲和LV (nal-IRI_5FU_LV) 是BTC的最有前途的二线疗法.
- 纳尔-IRI_5FU_LV在一线凝素加失败后改善整体存活率 (OS) 和无进展存活率 (PFS).
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
173
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
173


